Followers | 14 |
Posts | 3835 |
Boards Moderated | 1 |
Alias Born | 07/07/2002 |
Tuesday, November 17, 2015 9:41:46 AM
The study findings, which were recently published at the American Heart Association Scientific Sessions, represent the most significant long-term outcomes to date with the Niobe system in VT and were considerably better than those in the manual catheter group.
“This study further supports the strength of the Niobe system in effectively finding and eliminating even the most difficult to treat arrhythmias,” said Andrea Natale, M.D., FACC, FHRS, Executive Medical Director of Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center. “Most notably, our findings revealed a substantially greater long-term success rate among the Niobe patient group – 81.2% compared to 69% for the manual catheter group – which we attribute to the system’s exceptional mapping capabilities and catheter tip control, enabling operators to accurately pinpoint, access and thoroughly ablate the affected scar area.”
https://finance.yahoo.com/news/multicenter-study-reveals-improved-long-140000833.html
Recent STXS News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/12/2024 04:15:05 AM
- Stereotaxis to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 09/09/2024 12:40:20 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/06/2024 08:06:02 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/06/2024 08:05:16 PM
- Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society’s HRX Congress • GlobeNewswire Inc. • 09/03/2024 12:53:04 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/23/2024 09:10:48 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/23/2024 09:06:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 05:40:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:07:26 PM
- Stereotaxis Reports 2024 Second Quarter Financial Results • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX • GlobeNewswire Inc. • 08/12/2024 08:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 01:05:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 08:05:18 PM
- Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024 • GlobeNewswire Inc. • 07/22/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 09:06:40 PM
- Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir • GlobeNewswire Inc. • 07/18/2024 08:13:00 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2024 06:35:22 PM
- Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment • GlobeNewswire Inc. • 05/29/2024 12:25:00 PM
- Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework • GlobeNewswire Inc. • 05/24/2024 12:37:00 PM
- First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology • GlobeNewswire Inc. • 05/22/2024 12:42:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 09:00:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 02:35:45 PM
- Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa • GlobeNewswire Inc. • 05/15/2024 12:52:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 08:10:46 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM